PROKERA

What is Prokera and what makes it so effective?

PROKERA® is the only FDA approved therapeutic device used by eye care practitioners around the world, to provide quick symptom relief and healing of ocular surface disease. It is made from amniotic membrane, which has remarkable healing properties. It has been clinically proven to treat the following anterior eye conditions:

  • Moderate to severe dry eye
  • Neurotrophic Persistent Epithelial Defect
  • Chemical burns
  • Salzmann’s Nodular Degeneration
  • Stevens-Johnson Syndrome
  • Recurrent Corneal Erosions
  • Severe Infectious Keratitis
  • Corneal Ulcers
  • Post PRK Haze
  • Severe Corneal Wounds
  • Corneal Abrasions/Wounds Corneal Wounds
  • Post DSEK for Bullous Keratopathy

PROKERA is a biologic corneal bandage that contains the key catalyst for regenerative healing
– the heavy chain, high molecular weight hyaluronic acid/pentraxin-3 biologic signaling matrix.  The PROKERA lens is placed on the eye after local anesthetic drops and remains there for 3 to 6 days typically. You will return to the office to have it easily and safely removed.

FDA approved for:

  • Anti-scarring (scarring reduces vision)
  • Wound healing (ulcers and epithelial defects)
  • Anti-inflammation (inflammation causes pain and secondary tissue damage)
  • Anti-angiogenesis (i.e. blood vessel growth resistance, because the cornea is normally devoid of blood vessels and needs to remain an avascular structure to preserve its optical clarity)

PROKERA goes beyond symptom management to modulate inflammation and prevent scarring on the surface of your eye. Treating the ocular surface can be challenging, but PROKERA’s results have been game-changing. Traditional options typically address inflammation or management of healing, but not both, and many have adverse side effects. The only patients that should avoid this treatment are those that have glaucoma filtering implants or an allergy to Ciprofloxacin or Amphotericin B antibiotics. For more information, feel free to visit the PROKERA patient website here.